Martin P Béhé (Martin Béhé, Martin Behe)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Top Venues

Molecular pharmaceutics

EJNMMI research

ACS biomaterials science & engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Belinda Trachsel, Stefan Imobersteg, Giulia Valpreda, Gad Singer, Regula Grabherr, Mark Ormos, Irene Andrea Burger, Rahel A Kubik-Huch, Roger Schibli, Viola Vogel, Martin P Béhé
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI research 14 (1) (2024)
Belinda Trachsel, Stefan Imobersteg, Giulia Valpreda, Gad Singer, Regula Grabherr, Mark Ormos, Irene Andrea Burger, Rahel A Kubik-Huch, Roger Schibli, Viola Vogel, Martin P Béhé
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI research 14 (1) (2024)
Belinda Trachsel, Stefan Imobersteg, Giulia Valpreda, Gad Singer, Regula Grabherr, Mark Ormos, Irene Andrea Burger, Rahel A Kubik-Huch, Roger Schibli, Viola Vogel, Martin P Béhé
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI research 14 (1) (2024)
Kim E de Roode, Lieke Joosten, Martin P Béhé
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Kim E de Roode, Lieke Joosten, Martin P Béhé
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Marcus Gutmann, Debora Reinhardt, Christian Seidensticker, Martina Raschig, Lukas Hahn, Alessandra Moscaroli, Martin P Béhé, Lorenz Meinel, Tessa Lühmann
Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2. ACS biomaterials science & engineering (2023)
Belinda Trachsel, Giulia Valpreda, Alexandra Lutz, Roger Schibli, Linjing Mu, Martin P Béhé
Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Michal Grzmil, Fabius Wiesmann, Roger Schibli, Martin P Béhé
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. Cancers 15 (1) (2022)
Michal Grzmil, Fabius Wiesmann, Roger Schibli, Martin P Béhé
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. Cancers 15 (1) (2022)
Michal Grzmil, Fabius Wiesmann, Roger Schibli, Martin P Béhé
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. Cancers 15 (1) (2022)
Michal Grzmil, Paul Boersema, Ashish Sharma, Alain Blanc, Stefan Imobersteg, Martin Pruschy, Paola Picotti, Roger Schibli, Martin P Béhé
Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT). Journal of hematology & oncology 15 (1) (2022)
Nicolò Rigamonti, Niina Veitonmäki, Clara Domke, Sophie Barsin, Sarah Jetzer, Omar Abdelmotaleb, Ralph Bessey, Tamara Lekishvili, Francesca Malvezzi, Mariam Gachechiladze, Martin P Béhé, Victor Levitsky, Pamela A Trail
A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression. Cancer immunology research 10 (5) (2022)
Nathalie M Grob, Roger Schibli, Martin P Béhé, Thomas L Mindt
Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin 177Lu-PP-F11N. Cancers 13 (11) (2021)
Nina Romantini, Shahidul Alam, Stefanie Dobitz, Martin Spillmann, Martina De Foresta, Roger Schibli, Gebhard F X Schertler, Helma Wennemers, Xavier Deupi, Martin P Béhé, Philipp Berger
Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone. Proceedings of the National Academy of Sciences of the United States of America 118 (48) (2021)
Michal Grzmil, Stefan Imobersteg, Alain Blanc, Savas Deniz Soysal, Roger Schibli, Martin P Béhé
Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [ 177 Lu]Lu-PP-F11N. Pharmaceutics 13 (12) (2021)
Martin Spillmann, Larissa Thurner, Nina Romantini, Mirjam Zimmermann, Benoit Meger, Martin P Béhé, Maria Waldhoer, Gebhard F X Schertler, Philipp Berger
New Insights into Arrestin Recruitment to GPCRs. International journal of molecular sciences 21 (14) (2020)
Stefanie Dobitz, Patrick Wilhelm, Nina Romantini, Martina De Foresta, Cornelia Walther, Andreas Ritler, Roger Schibli, Philipp Berger, Xavier Deupi, Martin P Béhé, Helma Wennemers
Distance-Dependent Cellular Uptake of Oligoproline-Based Homobivalent Ligands Targeting GPCRs-An Experimental and Computational Analysis. Bioconjugate chemistry 31 (10) (2020)
Nathalie M Grob, Sarah Schmid, Roger Schibli, Martin P Béhé, Thomas L Mindt
Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions. Journal of medicinal chemistry 63 (9) (2020)
Nathalie M Grob, Daniel Häussinger, Xavier Deupi, Roger Schibli, Martin P Béhé, Thomas L Mindt
Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting. Journal of medicinal chemistry 63 (9) (2020)
Yun Qin, Stefan Imobersteg, Alain Blanc, Stephan Frank, Roger Schibli, Martin P Béhé, Michal Grzmil
Evaluation of Actinium-225 Labeled Minigastrin Analogue [225Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy. Pharmaceutics 12 (11) (2020)
Tessa Lühmann, Marcus Gutmann, Alessandra Moscaroli, Martina Raschig, Martin P Béhé, Lorenz Meinel
Biodistribution of Site-Specific PEGylated Fibroblast Growth Factor-2. ACS biomaterials science & engineering 6 (1) (2019)
Simon A M Kaeppeli, Andreas Jodal, Martin Gotthardt, Roger Schibli, Martin P Béhé
Exendin-4 Derivatives with an Albumin-Binding Moiety Show Decreased Renal Retention and Improved GLP-1 Receptor Targeting. Molecular pharmaceutics 16 (9) (2019)
Andreas Ritler, Michal S Shoshan, Xavier Deupi, Patrick Wilhelm, Roger Schibli, Helma Wennemers, Martin P Béhé
Elucidating the Structure-Activity Relationship of the Pentaglutamic Acid Sequence of Minigastrin with Cholecystokinin Receptor Subtype 2. Bioconjugate chemistry 30 (3) (2019)
Lieke Joosten, Maarten Brom, Hanneke Peeters, Sandra Heskamp, Martin P Béhé, Otto Boerman, Martin Gotthardt
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging. Molecular pharmaceutics 15 (2) (2017)
Alessandra Moscaroli, Gabriel Jones, Tessa Lühmann, Lorenz Meinel, Stephanie Wälti, Alain Blanc, Eliane Fischer, Manuel Hilbert, Roger Schibli, Martin P Béhé
Radiolabeled 111In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo Imaging. Molecular pharmaceutics 14 (3) (2017)